Skip to content

Development and validation of a post-stenting prognosis prediction model based on the imaging characteristics of pericarotid adipose tissue

Development and validation of a post-stenting prognosis prediction model based on the imaging characteristics of pericarotid adipose tissue

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125275
Enrollment
Unknown
Registered
2026-05-25
Start date
2025-11-10
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral vascular disease

Interventions

Retrospective training cohort (retrospective poor prognosis group):None
Retrospective training cohort (retrospective good prognosis group):None

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the retrospective cohort (1) Patients with carotid artery stenosis who underwent CAS surgery at Beijing Hospital and Beijing Tiantan Hospital in the past; (2) Stenosis location at the terminal segment of the common carotid artery and the C1 segment of the internal carotid artery, with a stenosis degree of more than 50%; (3) 18 years old =50% for symptomatic carotid artery stenosis patients and >=70% for asymptomatic carotid artery stenosis patients; (3) 18 years old <= patient age <= 80 years old; (4) Completed supra-aortic/head and neck CTA examination within 3 months before CAS surgery and retained the original phase information.

Exclusion criteria

Exclusion criteria: 1. Patients who underwent carotid artery occlusion surgery for acute occlusive disease of intracranial arteries; 2. Patients with severe stenosis in the intracranial arteries above the C2 segment of the internal carotid artery; 3. Patients with a history of neck radiotherapy or neck surgery, resulting in scar tissue hyperplasia around the internal carotid artery; 4. Patients without original phase information of supra-aortic/head and neck CTA; 5. Patients with a history of severe stroke, such as large-area cerebral infarction (preoperative mRS score greater than 3 points). Prospective cohort exclusion criteria: 1. Patients with non-atherosclerotic stroke mechanisms, including cardiogenic embolism (such as atrial fibrillation), carotid artery dissection, vasculitis, etc.; 2. Patients with malignant tumors and a history of systemic treatment; 3. Patients with severe underlying diseases that affect follow-up compliance, such as severe cognitive impairment, end-stage heart failure, etc.; 4. Patients with severe stenosis in the intracranial arteries above the C2 segment of the internal carotid artery; 5. Patients with incomplete general clinical baseline information and imaging data, or image quality not meeting the analysis requirements; 6. Patients with a history of neck radiotherapy or neck surgery; 7. Patients with a history of severe stroke, such as large-area cerebral infarction (preoperative mRS score greater than 3 points); 8. Patients with chronic atrial fibrillation, paroxysmal atrial fibrillation within the past 6 months or requiring anticoagulation therapy, myocardial infarction within 30 days, or unstable angina.

Design outcomes

Primary

MeasureTime frame
Performance metrics of carotid perivascular adipose tissue (PVAT) automated segmentation model (Dice coefficient, recall);Performance metrics of post-CAS ischemic risk prediction model (AUC, sensitivity, specificity);

Secondary

MeasureTime frame
Data quality and feasibility metrics (intraclass correlation coefficient, follow-up completion rate);Model generalizability metrics (external validation AUC, subgroup analysis performance);

Countries

China

Contacts

Public ContactQi Peng

Beijing Hospital

qipeng2008@aliyun.com+86 138 1167 0109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026